Delivery Order SPE2DB22D9316-SPE2DB24FYP77

Award Date 7/22/24
Potential Completion Date 8/12/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $78,783.00 firm fixed-price delivery order is for the supply of 4556749427 PERJETA 420 MG/14 ML VIAL 14ML to support the medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $36,458.16 firm fixed-price delivery order is for the supply of PERJETA 420 MG/14 ML VIAL 14ML, a prescription drug product. The contract has an ultimate completion date of June 20, 2025 and is not designated as a set-aside. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a $8,509.92 firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4564403579 - PERJETA 420 MG/14 ML VIAL 14ML, with a completion date of May 15, 2024. DMS Pharmaceutical Group is an experienced pharmaceutical wholesaler that provides a wide range of branded and generic drugs, biologics, and medical supplies to support the recurring...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $25,529.76 firm fixed-price delivery order is for the supply of PERJETA 420 MG/14 ML VIAL 14ML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS...
This federal contract award, valued at $9,114.54, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4567172469 ! PERJETA 420 MG/14 ML VIAL 14ML, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $17,019.84 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4563691587 PERJETA 420 MG/14 ML VIAL 14ML pharmaceutical products. This order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with DLA, which has a potential value of up to $4,999,999 and enables the agency to...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,254.96 firm fixed-price contract is for the procurement of PERJETA 420 MG/14 ML VIAL 14ML, a specialty oncology drug. The contract is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,254.96 award is for the supply of PERJETA 420 MG/14 ML VIAL 14ML, a specialized oncology drug, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,756.60 contract covers the delivery of 4556522685 - PERJETA 420 MG/14 ML VIAL 14ML, a specialized oncology medication, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order, with a firm fixed price, to supply 4565763622 PERJETA 420 MG/14 ML VIAL 14ML. The contract has a ceiling value of $21,274.80 and a completion date of September 27, 2024. The contract is part of a larger indefinite delivery contract (IDC) that DMS Pharmaceutical Group...
  • SPE2DB22D9316
    Indefinite Delivery Contract
  • SPE2DB22D9316-SPE2DB24FYP77
    Delivery Order

This federal contract award, valued at $12,764.88, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4565242595 PERJETA 420 MG/14 ML VIAL 14ML, with an ultimate completion date of August 12, 2024.

DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The current award is issued under this IDC, further solidifying DMS Pharmaceutical Group's position as a crucial supplier in the federal pharmaceutical supply chain.

Generated 10/21/24, 9:24 AM